The global market holds a valuation of USD 16.9 billion by the end of the year 2022 and further, expand at a CAGR of 6.2% to reach a valuation of ~USD 32.6 billion by the year 2033. According to a recent, study by Future Market Insights, polymers packaging materials are expected to hold the highest share of 88.3% in the year 2023, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 16.9 billion |
| Market Value 2033 | USD 32.6 billion |
| CAGR 2022 to 2033 | 6.2% |
| Market Share of Top 5 Countries | 55.2% |
| Key Market Players | AstraZeneca; Cipla Ltd.; Johnson & Johnson Pacific Pty Limited; GlaxoSmithKline plc.; Novartis International AG; The Procter & Gamble Company; sanofi-aventis LLC.; Alcon Inc.'s; Meda Pharmaceuticals Inc.; Perrigo Company plc; Sunovion Pharmaceuticals Canada, Inc.; Boehringer Ingelheim; Covis Pharma S.a.r.l.; AdvaCare Pharma; NIPRO JMI Pharma Ltd.; Bayer Consumer Health.; AptarGroup, Inc.; Berry Global, Inc.; URSATEC GmbH; Gerresheimer AG; Bona PHARMA; Avantor; VWR International, LLC; Spectrum Laboratory Products, Inc.; SKS Bottle & Packaging, Inc.; Coster Tecnologie Speciali S.p.A.; Clear Sky d.o.o. |
Inhaling liquid medications through the nose is done with nasal sprays. They are employed in order to minimize and decrease nasal congestion. Colds or allergies can manifest as congestion. Nasal sprays can be purchased over the counter or via prescription.
Different types of nasal sprays, such as nasal steroid sprays, nasal antihistamine sprays, nasal anticholinergic sprays, nasal cromolyn sprays, and nasal decongestant sprays, are used to administer drugs locally in the nasal cavities or systemically.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for the market was approximately 23.5% of the overall USD 71.9 billion of the global nasal drug delivery technology market in 2022.
The sale of the market expanded at a CAGR of 5.8% from 2015 to 2022.
The rise in allergies and infectious diseases is responsible for the market's expansion. It is possible that a number of benefits, including painless and effective drug delivery and simplicity of accessibility, helped to broaden the market's reach during the previous years.
The rise in chronic respiratory disorders is to blame for the market's expansion throughout the mentioned forecast period. In 2019, The Global Asthma Report estimates that 330 million individuals worldwide had asthma, with a potential 400 million cases by 2025.
A variety of market participants have launched new products as a result of the rising prevalence of chronic respiratory illnesses.
The number of people experiencing allergic symptoms like colds, congestion, sneezing, and runny noses is on the rise. However, they can also be utilized for other conditions, such as migraines. Additionally, a substantial increase in the prescription of specific medications following post-operative procedures is a factor that is anticipated to increase the use of nasal spray as an anti-allergic drug.
Due to the considerable increase in the incidence of major depressive disorders, there has been an increased focus on mental illnesses recently. One of these is depression, which is a prevalent mental illness.
Over 280 million individuals of all ages, according to a WHO report from 2021, experience depression. In addition to being a key factor in the overall global burden of diseases, depression is one of the primary causes of disability worldwide.
Principal Consultant
Throughout the projection period, a number of negative nasal spray effects are anticipated to impede market expansion. Nasal spray can cause itching, redness, and swelling in the nose, which might restrict its use and hamper the market growth.
Another potential issue restricting market expansion is anticipated to be regulatory barriers brought on by strict drug sales regulations in nations like Russia and Mexico.
Growing cardiovascular health risks, nasal irritation, and nasal congestion are other variables impeding market expansion during the evaluation period.
The USA dominates the North American region and is anticipated to hold 31.4% of the total global market share of 2023 and is expected to continue to experience the same growth throughout the forecast period.
Due to rising rates of allergies and depressive episodes, there is a growing demand for nasal sprays in the United States. In order to comply with new regulatory requirements, the USA is primarily focused on branded nasal manufacturers interested in developing unique products.
The market growth is anticipated to accelerate during the forecast period due to the increased patient preference for nasal medication delivery due to its simplicity of administration and superior efficacy characteristics.
During the forecast period, China is set to exhibit growth at a CAGR of nearly 6.6% in the global market.
The second-largest pharmaceutical industry in the world, China is expanding quickly due to two key factors: significant capital expenditure, and a rise in productivity. These two elements suggest a desirable location for both significant local savings and foreign investment. The nation has been evolving from a low-income nation to one that is increasingly market-oriented since the 1970s.
An aging population, expanding government spending, and rising consumer affluence are driving China’s market. Increasing player alliances and partnerships are predicted to propel regional market growth over the forecast period.
Germany holds approximately 17.0% share of the European market in 2022 and is projected to display growth at a lucrative CAGR during the forecast period.
One of the top countries in the world for pharmaceutical manufacture is Germany. The nation's manufacturers get a competitive edge by creating goods and using cutting-edge research to solve unmet problems. Additionally, the manufacturers are always making investments to increase their operations because doing so will allow them to undertake greater Research and Development (R&D) activities, which will result in a pipeline that is more promising. Furthermore, it is focusing on developing novel products in these areas in order to generate significant returns by selecting regions with a high level of unmet patient requirements.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Based on product sales, nasal steroid sprays are the most popular and are anticipated to hold a market share of 45.1% in 2023 nasal steroid sprays have the largest market share among all product categories in the world.
In order to treat nasal allergy symptoms like sneezing and runny nose, nasal steroid sprays inject a corticosteroid directly into the nose. These sprays can relieve hay fever or nasal allergies, and they frequently take the place of other oral allergy treatments. To continue to feel better during allergy season, one must use them every day.
The category is anticipated to maintain its high market share during the forecast period due to the commercialization of affordable generics of nasal steroid spray and its convenient availability throughout Europe countries.
The aqueous formulation is anticipated to hold 53.3% of the market share in 2023 in terms of formulation. The aqueous formulation is anticipated to dominate the nasal spray market for the projected period.
Aqueous formulation administers medications either locally or systemically through the nose. They are applied locally to treat conditions like allergic rhinitis and nasal congestion, as it offers a good option for injection or pill. Hence, the aqueous formulation is used more than hydroalcoholic, or nonaqueous-based solution, suspension, or emulsion systems.
Polymer packaging material is expected to dominate the packaging material segment with 88.3% of the global market in 2023.
The barrier qualities of polymers are advantageous because they prolong shelf life, keep products clean, and prevent contamination. Less wear is also largely owed to the low frictional characteristics.
Packaging made of polymers is often lighter, which lowers the manufacturer's transportation costs. While glass packaging uses a lot of energy. This occurs as a result of the high temperature needed for manufacturing processing, hence the use of polymers is high.
Pump bottles in the packaging category are expected to account for 73.8% of the overall market share in 2023.
The pump bottles' superior dosing accuracy is responsible for their dominance in the market. Since pressurized sprays are difficult to use with high-viscosity solutions, the product is becoming more popular. As a result, the market is expected to grow quickly now and over the next ten years.
Nasal pump bottles are easy to use and can be easily available hence the use of nasal pump bottles is increasing.
The report predicts that throughout the projected period, the institutional sales segment would dominate the worldwide nasal spray market. In terms of distribution channels, the institutional sales sector is expected to hold 56.4% of the overall market share in 2023. The rising cost of healthcare and strong sales of generic drugs are responsible for the segment's dominance.
Institutional sales dominate because most physicians prescribe nasal spray to treat people experiencing allergic symptoms like colds, congestion, sneezing, and runny noses are on the rise.
Due to the existence of top players operating in this industry, the nasal spray market is highly fragmented. Many clinical and research sectors are concentrating on research and development activities primarily for allergic reactions.
As a result, market participants are also working to increase their local and worldwide footprint through product launches, acquisitions, and distribution channel improvements.
For Instance,
Similarly, the team at Future Market Insights has tracked recent developments related to companies manufacturing nasal sprays, which is available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Formulation, Packaging Material, Packaging, Distribution Channel, and Region |
| Key Companies Profiled | AstraZeneca; Cipla Ltd.; Johnson & Johnson Pacific Pty Limited; GlaxoSmithKline plc.; Novartis International AG; The Procter & Gamble Company; sanofi-aventis LLC.; Alcon Inc.'s; Meda Pharmaceuticals Inc.; Perrigo Company plc; Sunovion Pharmaceuticals Canada Inc.; Boehringer Ingelheim; Covis Pharma S.a.r.l.; AdvaCare Pharma; NIPRO JMI Pharma Ltd.; Bayer Consumer Health.; AptarGroup, Inc.; Berry Global, Inc.; URSATEC GmbH; Gerresheimer AG; Bona PHARMA; Avantor, VWR International, LLC; Spectrum Laboratory Products, Inc.; SKS Bottle & Packaging, Inc.; Coster Tecnologie Speciali S.p.A; Clear Sky d.o.o. |
| Pricing | Available upon Request |
North America is projected to emerge as a lucrative market.
The growth potential of the market is 6.2% through 2033.
Stringent regulations are likely to limit market growth.
The United States is likely to capture a high share of the global market.
The market is estimated to secure a valuation of USD 16.9 million in 2022.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 6. Global Market Demand (in Volume) Analysis 2015 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD million) Analysis 2015 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Product 9.1. Nasal Steroid Sprays 9.2. Nasal Antihistamine Sprays 9.3. Decongestant Sprays 9.4. Nasal Anticholinergic Sprays 9.5. Nasal Triamcinolone Sprays 9.6. Nasal Cromolyn Sodium Sprays 9.7. Others 10. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Formulation 10.1. Aqueous 10.2. Hydroalcoholic 10.3. Nonaqueous-Based Solution 10.4. Suspension 10.5. Emulsions 10.6. Dry Powder/Microparticles 11. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Packaging Material 11.1. Polymers 11.2. Glass 12. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Packaging 12.1. Pump Bottles 12.2. Pressurized Canisters 13. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Distribution Channel 13.1. Institutional Sales 13.1.1. Hospitals 13.1.2. Specialty Clinics 13.1.3. Community Clinics 13.1.4. Public Health Agencies 13.1.5. Others 13.2. Retail Sales 13.2.1. Retail Pharmacies 13.2.2. Drug Stores 13.3.3. Mail Order Pharmacy 14. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Region 14.1. Middle East and Africa 14.2. Latin America 14.3. Europe 14.4. South Asia 14.5. East Asia 14.6. Oceania 14.7. Middle East and Africa (MEA) 15. North America Market Analysis 2015 to 2022 and Forecast 2023 to 2033 16. Latin America Market Analysis 2015 to 2022 and Forecast 2023 to 2033 17. Europe Market Analysis 2015 to 2022 and Forecast 2023 to 2033 18. South Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033 19. East Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033 20. Oceania Market Analysis 2015 to 2022 and Forecast 2023 to 2033 21. Middle East and Africa (MEA) Market Analysis 2015 to 2022 and Forecast 2023 to 2033 22. Market Structure Analysis 23. Competition Analysis 23.1. Astra Zeneca Plc. 23.2. Cipla Ltd. 23.3. Johnson & Johnson Pacific Pty Limited 23.4. GlaxoSmithKline plc. 23.5. Novartis International AG 23.6. The Procter & Gamble Company 23.7. sanofi-aventis LLC. 23.8. Alcon Inc.'s 23.9. Meda Pharmaceuticals Inc. 23.10. Perrigo Company plc 23.11. Sunovion Pharmaceuticals Canada Inc. 23.12. Boehringer Ingelheim 23.13. Covis Pharma S.a.r.l. 23.14. AdvaCare Pharma 23.15. NIPRO JMI Pharma Ltd. 23.16. Bayer Consumer Health 23.17. AptarGroup, Inc. 23.18. Berry Global, Inc. 23.19. URSATEC GmbH 23.20. Gerresheimer AG 23.21. Bona PHARMA 23.22. Avantor, VWR International, LLC 23.23. Spectrum Laboratory Products, Inc. 23.24. SKS Bottle & Packaging, Inc. 23.25. Coster Tecnologie Speciali S.p.A 23.26. Clear Sky d.o.o. 24. Assumptions and Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports
Nasal Sprays Market
